- Home
- MUX vs CELC Comparison
MUX vs CELC Comparison
Compare MUX & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUX
- CELC
- Stock Information
- Founded
- MUX 1979
- CELC 2011
- Country
- MUX Canada
- CELC United States
- Employees
- MUX N/A
- CELC N/A
- Industry
- MUX Precious Metals
- CELC Medical Specialities
- Sector
- MUX Basic Materials
- CELC Health Care
- Exchange
- MUX Nasdaq
- CELC Nasdaq
- Market Cap
- MUX 518.8M
- CELC 440.0M
- IPO Year
- MUX N/A
- CELC 2017
- Fundamental
- Price
- MUX $10.95
- CELC $13.78
- Analyst Decision
- MUX Strong Buy
- CELC Strong Buy
- Analyst Count
- MUX 2
- CELC 6
- Target Price
- MUX $15.25
- CELC $30.67
- AVG Volume (30 Days)
- MUX 924.6K
- CELC 210.9K
- Earning Date
- MUX 08-06-2025
- CELC 08-13-2025
- Dividend Yield
- MUX N/A
- CELC N/A
- EPS Growth
- MUX N/A
- CELC N/A
- EPS
- MUX N/A
- CELC N/A
- Revenue
- MUX $168,945,000.00
- CELC N/A
- Revenue This Year
- MUX $1.09
- CELC N/A
- Revenue Next Year
- MUX N/A
- CELC N/A
- P/E Ratio
- MUX N/A
- CELC N/A
- Revenue Growth
- MUX N/A
- CELC N/A
- 52 Week Low
- MUX $6.38
- CELC $7.58
- 52 Week High
- MUX $11.46
- CELC $19.77
- Technical
- Relative Strength Index (RSI)
- MUX 63.59
- CELC 63.64
- Support Level
- MUX $10.36
- CELC $13.35
- Resistance Level
- MUX $11.11
- CELC $14.50
- Average True Range (ATR)
- MUX 0.47
- CELC 0.74
- MACD
- MUX -0.00
- CELC 0.06
- Stochastic Oscillator
- MUX 74.18
- CELC 75.88
About MUX McEwen Mining Inc.
McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company primarily generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, most production occurs in the United States.
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.